| Date Filed | Type | Description |
| 05/15/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/28/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/20/2012 |
4
| Fonstein Michael (President) has filed a Form 4 on CLEVELAND BIOLABS INC|
Txns:
| Sold 44,399 shares
@ $3.1225, valued at
$138.6k
Sold 35,601 shares
@ $3.0404, valued at
$108.2k
Sold 20,000 shares
@ $2.9448, valued at
$58.9k
|
|
| 03/20/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/25/2012 |
4
| Fonstein Michael (President) has filed a Form 4 on CLEVELAND BIOLABS INC|
Txns:
| Granted 56,250 options to buy
@ $3.35, valued at
$188.4k
|
|
| 09/07/2011 |
4
| Fonstein Michael (CEO and President) has filed a Form 4 on CLEVELAND BIOLABS INC|
Txns:
| Bought 2,200 shares
@ $2.27, valued at
$5k
|
|
| 03/22/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/04/2011 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/20/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/22/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/23/2010 |
4
| Fonstein Michael (CEO, President) has filed a Form 4 on CLEVELAND BIOLABS INC|
Txns:
| Sold 300 shares
@ $3.56, valued at
$1.1k
Sold 666 shares
@ $3.55, valued at
$2.4k
Sold 300 shares
@ $3.59, valued at
$1.1k
Sold 2,334 shares
@ $3.58, valued at
$8.4k
Sold 1,400 shares
@ $3.57, valued at
$5k
|
|
| 02/23/2010 |
4
| Fonstein Michael (CEO, President) has filed a Form 4 on CLEVELAND BIOLABS INC|
Txns:
| Sold 1,000 shares
@ $3.87, valued at
$3.9k
Sold 200 shares
@ $3.88, valued at
$776
Sold 1,900 shares
@ $3.89, valued at
$7.4k
Sold 1,900 shares
@ $3.9, valued at
$7.4k
|
|
| 02/11/2010 |
SC 13G
| Fonstein Michael reports a 7.2% stake in Cleveland BioLabs, Inc. |
| 01/25/2010 |
4
| Fonstein Michael (CEO, President) has filed a Form 4 on CLEVELAND BIOLABS INC|
Txns:
| Sold 600 shares
@ $3.97, valued at
$2.4k
Sold 1,200 shares
@ $3.92, valued at
$4.7k
Sold 100 shares
@ $3.94, valued at
$394
Sold 1,300 shares
@ $3.81, valued at
$5k
Sold 1,800 shares
@ $3.82, valued at
$6.9k
|
|
| 01/04/2010 |
4
| Fonstein Michael (CEO, President) has filed a Form 4 on CLEVELAND BIOLABS INC|
Txns:
| Sold 751 shares
@ $3.55, valued at
$2.7k
Sold 200 shares
@ $3.6, valued at
$720 |
|
| 12/28/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/28/2009 |
4/A
| Fonstein Michael (CEO, President) has filed a Form 4 on CLEVELAND BIOLABS INC|
Txns:
| Sold 100 shares
@ $3.66, valued at
$366
Sold 100 shares
@ $3.72, valued at
$372 |
|
| 11/23/2009 |
4
| Fonstein Michael (CEO, President) has filed a Form 4 on CLEVELAND BIOLABS INC|
Txns:
| Sold 400 shares
@ $3.57, valued at
$1.4k
Sold 700 shares
@ $3.59, valued at
$2.5k
Sold 1,100 shares
@ $3.6, valued at
$4k
Sold 300 shares
@ $3.61, valued at
$1.1k
Sold 1,800 shares
@ $3.62, valued at
$6.5k
Sold 500 shares
@ $3.63, valued at
$1.8k
Sold 100 shares
@ $3.66, valued at
$366
Sold 100 shares
@ $3.72, valued at
$372 |
|
| 09/23/2009 |
4
| Fonstein Michael (CEO & President) has filed a Form 4 on CLEVELAND BIOLABS INC |
| 02/13/2009 |
SC 13G
| Form SC 13G -- Statement of acquisition of beneficial ownership by individuals |
| 02/11/2008 |
SC 13G
| Fonstein Michael reports a 10.4% stake in Cleveland BioLabs, Inc. |
| 02/14/2007 |
SC 13G
| Fonstein Michael reports a 11.1% stake in Cleveland BioLabs, Inc. |